Clinic
Winnsboro Medical Clinic
Winnsboro Medical Clinic was paid $5.18M by Medicaid between Jan 2018 and Dec 2024, across 97 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 29% of everything it billed.
33Billing provider infoWINNSBORO MEDICAL CLINIC
WINNSBORO, LA 71295
WINNSBORO, LA 71295
33aNPI1780621326assigned 06/01/2006
33bProvider typePrimary Care Clinic/Center
28Total paid$5.18M
24GClaims209,673
24DCodes billed97
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Primary Care Clinic/Center providers in Louisiana
Rank by total paid#3 of 92
Median peer was paid$157K
This provider vs. median33×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 26,289 | $429K | |
| 2019 | 31,254 | $676K | |
| 2020 | 25,282 | $758K | |
| 2021 | 30,654 | $1.06M | |
| 2022 | 37,473 | $863K | |
| 2023 | 34,442 | $794K | |
| 2024incomplete | 24,279 | $595K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 29% | 43,753 | 36,318 | $1.49M |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 21% | 4,317 | 3,400 | $1.09M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 18% | 20,034 | 16,590 | $919K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 8.0% | 1,215 | 1,143 | $414K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 3.2% | 2,531 | 1,995 | $167K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.8% | 28,808 | 23,513 | $143K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 2.0% | 1,670 | 1,410 | $103K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1.3% | 2,515 | 2,221 | $70K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.3% | 2,436 | 1,924 | $65K |
| 80050 | General health panel | 1.2% | 2,083 | 1,937 | $60K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 1.1% | 880 | 831 | $58K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.1% | 11,611 | 6,252 | $55K |
85 more codes
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 1.0% | 573 | $53K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 2,795 | $36K |
| 80061 | Lipid panel | <1% | 4,551 | $33K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 483 | $33K |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 2,615 | $31K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,849 | $30K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 456 | $28K |
| 84439 | <1% | 4,102 | $23K | |
| 81000 | <1% | 8,145 | $18K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 3,693 | $16K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 505 | $16K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 504 | $16K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 503 | $15K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 208 | $15K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 1,192 | $12K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 947 | $12K |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 221 | $12K |
| 87634 | <1% | 243 | $12K | |
| 81025 | <1% | 2,255 | $12K | |
| 92551 | <1% | 1,489 | $12K | |
| 80053 | Comprehensive metabolic panel | <1% | 3,726 | $11K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 8,191 | $9K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,765 | $9K |
| 74018 | <1% | 595 | $9K | |
| 83735 | <1% | 2,101 | $9K | |
| 85004 | <1% | 1,348 | $7K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 145 | $7K |
| 36415 | Collection of venous blood by venipuncture | <1% | 4,077 | $7K |
| 83970 | <1% | 298 | $6K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 121 | $4K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 379 | $4K |
| 82043 | <1% | 1,060 | $3K | |
| 99173 | <1% | 1,546 | $3K | |
| 90686 | <1% | 337 | $3K | |
| 82570 | <1% | 826 | $2K | |
| 84436 | <1% | 1,480 | $2K | |
| 84479 | <1% | 1,480 | $2K | |
| G0181 | Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allowed practitioner development and/or revision of care plans | <1% | 94 | $2K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 149 | $2K |
| 82607 | <1% | 178 | $1K | |
| 82746 | <1% | 174 | $1K | |
| 99205 | Prolong outpt/office vis | <1% | 12 | $1K |
| 86308 | <1% | 252 | $1K | |
| 99490 | Ccm add 20min | <1% | 408 | $1K |
| 84153 | <1% | 77 | $915.00 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 7,005 | $666.09 |
| 72100 | <1% | 27 | $612.25 | |
| 82441 | <1% | 158 | $501.48 | |
| 77080 | <1% | 15 | $492.16 | |
| 93000 | <1% | 48 | $426.27 | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 12 | $327.72 |
| 90474 | <1% | 41 | $292.16 | |
| 87400 | <1% | 34 | $286.50 | |
| 73560 | <1% | 13 | $221.04 | |
| 84550 | <1% | 56 | $206.54 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,325 | $199.48 |
| 82728 | <1% | 12 | $121.95 | |
| 86200 | <1% | 17 | $100.24 | |
| 90715 | <1% | 27 | $98.64 | |
| 83550 | <1% | 12 | $78.39 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 18 | $47.25 |
| 3078F | <1% | 75 | $43.00 | |
| 3074F | <1% | 85 | $40.00 | |
| J2800 | Injection, methocarbamol, up to 10 ml | <1% | 49 | $18.79 |
| 3079F | <1% | 24 | $10.00 | |
| J0945 | Injection, brompheniramine maleate, per 10 mg | <1% | 110 | $1.26 |
| 90633 | <1% | 339 | $0.34 | |
| 90651 | <1% | 49 | $0.03 | |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 1,646 | $0.00 |
| 90697 | 0% | 69 | $0.00 | |
| G8418 | Bmi is documented below normal parameters and a follow-up plan is documented | 0% | 897 | $0.00 |
| 90620 | 0% | 14 | $0.00 | |
| 90619 | 0% | 38 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 0% | 116 | $0.00 |
| 90723 | 0% | 122 | $0.00 | |
| 90680 | 0% | 88 | $0.00 | |
| 90670 | 0% | 591 | $0.00 | |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 3,889 | $0.00 |
| G8539 | Functional outcome assessment documented as positive using a standardized tool and a care plan based on identified deficiencies is documented within two days of the functional outcome assessment | 0% | 984 | $0.00 |
| 90671 | 0% | 117 | $0.00 | |
| 90734 | 0% | 56 | $0.00 | |
| 90648 | 0% | 339 | $0.00 | |
| 90710 | 0% | 33 | $0.00 | |
| 90662 | 0% | 45 | $0.00 | |
| 90658 | 0% | 77 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialREED, CHARLES (PHYSICIAN)